UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.143

Sortiert nach

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial

The Journal of thoracic and cardiovascular surgery, 2019-09, Vol.158 (3), p.895-907

2019

Link zum Volltext

Verfügbarkeit prüfen

A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer

The Journal of thoracic and cardiovascular surgery, 2022-01, Vol.163 (1), p.289-301.e2

2022

Link zum Volltext

Verfügbarkeit prüfen

Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung

Clinical cancer research, 2017-02, Vol.23 (3), p.757-765

2017

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

The New England journal of medicine, 2020-10, Vol.383 (18), p.1711-1723

2020

Link zum Volltext

Verfügbarkeit prüfen

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201

The Journal of thoracic and cardiovascular surgery, 2013-07, Vol.146 (1), p.24-30

2013

Link zum Volltext

Verfügbarkeit prüfen

Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma

The Annals of thoracic surgery, 2019-07, Vol.108 (1), p.249-255

2019

Link zum Volltext

Verfügbarkeit prüfen

Collagen type I induces EGFR‐TKI resistance in EGFR‐mutated cancer cells by mTOR activation through Akt‐independent pathway

Cancer science, 2018-06, Vol.109 (6), p.2063-2073

2018

Link zum Volltext

Verfügbarkeit prüfen

Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review

Japanese journal of clinical oncology, 2017-01, Vol.47 (1), p.7-11

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer

Expert review of anticancer therapy, 2022-02, Vol.22 (2), p.169-182

2022

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-07, Vol.38 (19), p.2187-2196

2020

Link zum Volltext

Verfügbarkeit prüfen

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC

Journal of thoracic oncology, 2022-03, Vol.17 (3), p.423-433

2022

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)

Journal of thoracic oncology, 2011-04, Vol.6 (4), p.751-756

2011

Link zum Volltext

Verfügbarkeit prüfen

Refractory Hepatic Lymphorrhea: Percutaneous Transhepatic Lymphangiography and Embolization with n-Butyl-2-Cyanoacrylate Glue

Cardiovascular and interventional radiology, 2021-07, Vol.44 (7), p.1127-1130

2021

Link zum Volltext

Verfügbarkeit prüfen

Multicentre prospective observational study for pulmonary vein stump thrombus after anatomical lung resections

European journal of cardio-thoracic surgery, 2021-12, Vol.61 (1), p.92-99

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC

Journal of thoracic oncology, 2019-08, Vol.14 (8), p.1408-1418

2019

Link zum Volltext

Verfügbarkeit prüfen

The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

Journal of thoracic oncology, 2020-09, Vol.15 (9), p.1434-1448

2020

Link zum Volltext

Verfügbarkeit prüfen

Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma

Lung cancer (Amsterdam, Netherlands), 2021-03, Vol.153, p.1-10

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L)

Japanese journal of clinical oncology, 2010-03, Vol.40 (3), p.271-274

2010

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib

Clinical cancer research, 2006-10, Vol.12 (19), p.5764-5769

2006

Link zum Volltext

Verfügbarkeit prüfen

ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection

Clinical lung cancer, 2018-07, Vol.19 (4), p.e533-e536

2018

Link zum Volltext

Verfügbarkeit prüfen

Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non–Small Cell Lung Cancer: A Propensity Score Matching Study

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.85-93

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4244-4252

2008

Link zum Volltext

Verfügbarkeit prüfen

Uptake of collagen type I via macropinocytosis cause mTOR activation and anti-cancer drug resistance

Biochemical and biophysical research communications, 2020-05, Vol.526 (1), p.191-198

2020

Link zum Volltext

Verfügbarkeit prüfen

Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival

European journal of cardio-thoracic surgery, 2016-03, Vol.49 (3), p.847-853

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(890)
Mit Volltextzugriff
(1.065)

Publikationsform

Sprache

Englisch
(973)
Japanisch
(446)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial

A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer

Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma

Collagen type I induces EGFR‐TKI resistance in EGFR‐mutated cancer cells by mTOR activation through Akt‐independent pathway

Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review

Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer

Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC

A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)

Refractory Hepatic Lymphorrhea: Percutaneous Transhepatic Lymphangiography and Embolization with n-Butyl-2-Cyanoacrylate Glue

Multicentre prospective observational study for pulmonary vein stump thrombus after anatomical lung resections

Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC

The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma

A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L)

Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib

ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection

Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non–Small Cell Lung Cancer: A Propensity Score Matching Study

Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

Uptake of collagen type I via macropinocytosis cause mTOR activation and anti-cancer drug resistance

Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival

Suchergebnisse filtern